MedTrace Logo

Trial Evaluating Transvaginal Electrical Stimulation With a Home Use Programmable Device for Urinary Stress Incontinence

NCT00762593 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2008-10-17

No results posted yet for this study

Summary

To compare the effectiveness of a transvaginal electrical stimulation by a home use programmable device to a placebo device for urinary incontinence in women

Conditions

  • Urinary Stress Incontinence

Interventions

DEVICE

transvaginal placebo device

Use of a transvaginal placebo home use programmable device used 30 minutes every day during 8 weeks

DEVICE

transvaginal electrical stimulation device

Use of a transvaginal electrical stimulation home use programmable device used 30 minutes every day during 8 weeks

Sponsors & Collaborators

  • Akontis

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2008-10-31
Completion
2008-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00762593 on ClinicalTrials.gov